Avricore Health (AVCRF) Return on Capital Employed (2012 - 2025)
Avricore Health (AVCRF) posted quarterly Return on Capital Employed of 75.62% for Q3 2025, down 8036.0% YoY from 0.95% in Q3 2024, and down 105.36% sequentially from 36.82% in Q2 2025.
Avricore Health (AVCRF) Return on Capital Employed (2012 - 2025) Analysis & Trends
Avricore Health has disclosed Return on Capital Employed across 13 years of filings, most recently posting 75.62% for Q3 2025.
- In Q3 2025, Return on Capital Employed fell 8036.0% year-over-year to 75.62%; the TTM figure through Sep 2025 stood at 75.62% (down 8036.0% YoY), while the FY2025 annual figure was 176.74%, down 18280.0% from the prior year.
- Return on Capital Employed eased to 75.62% in Q3 2025, from 36.82% in the prior quarter.
- Over the last five years, Return on Capital Employed for AVCRF reached as high as 4.74% in Q3 2024 and fell as low as 75.62% in Q3 2025.
- The 5-year median for Return on Capital Employed is 17.88% (2022), against an average of 21.39%.
- Annual changes were most pronounced in 2021 — Return on Capital Employed slumped 13246 bps — and 2024, when it soared 4765 bps.
- A 5-year view of Return on Capital Employed shows it stood at 11.03% in 2021, then slumped by 242 bps to 37.67% in 2022, then jumped by 45 bps to 20.7% in 2023, then jumped by 123 bps to 4.74% in 2024, then plunged by 1696 bps to 75.62% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 75.62%, 36.82%, and 1.67% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 67.98% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -3.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 14.57% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 45.73% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -75.62% |
| Jun 30, 2025 | -36.82% |
| Mar 31, 2025 | -1.67% |
| Sep 30, 2024 | 4.74% |
| Jun 30, 2024 | -0.27% |
| Mar 31, 2024 | -16.58% |
| Dec 31, 2023 | -20.70% |
| Sep 30, 2023 | -42.91% |
| Jun 30, 2023 | -33.04% |
| Mar 31, 2023 | -27.43% |
| Dec 31, 2022 | -37.67% |
| Sep 30, 2022 | -31.09% |
| Jun 30, 2022 | -19.17% |
| Mar 31, 2022 | -10.62% |
| Dec 31, 2021 | -11.03% |
| Sep 30, 2021 | -8.16% |
| Jun 30, 2021 | -7.29% |
| Mar 31, 2021 | -9.71% |
| Dec 31, 2020 | 15.46% |
| Sep 30, 2020 | 31.75% |